Insider · CIK 0001776953
Adel Mekhail
Files at PBH (Prestige Consumer Healthcare Inc.). First filing Nov 14, 2024, latest Nov 14, 2024.
Adel Mekhail files SEC Form 4 as officer at PBH (Prestige Consumer Healthcare Inc.). Since Nov 14, 2024, Adel Mekhail has reported 0 open-market buys worth $0 and 1 open-market sell worth $743k, the latest filed on Nov 14, 2024.
A track record needs three past buys with six months of prices behind them; Adel Mekhail has 0, so none is measured yet.
The newest scored trade: sold $743k of PBH on Nov 12, 2024, filed Nov 14, 2024, scored 46 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PBH: Prestige Consumer Healthcare Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 46Moderate | Prestige Consumer Healthcare Inc. | $743k 9,063 shares | -33% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Feb 11, 2025 | PBH Prestige Consumer Healthcare Inc. | 11,083 0.02% of outstanding | $956k | Feb 11, 2025 | $743k |
| Nov 12, 2024 | PBH Prestige Consumer Healthcare Inc. | 9,063 0.02% of outstanding | $743k | Nov 12, 2024 | none |
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 7, 2025 | PBH Prestige Consumer Healthcare Inc. | FTax withholding Common Stock, par value $0.01 per share | -457 | $81.41 | $37k | 20,908 | May 9, 2025 |
| May 5, 2025 | PBH Prestige Consumer Healthcare Inc. | AGrant or award Common Stock, par value $0.01 per share | +2,622 | $0.00 | $0 | 21,365 | May 7, 2025 |
| May 2, 2025 | PBH Prestige Consumer Healthcare Inc. | FTax withholding Common Stock, par value $0.01 per share | -463 | $84.19 | $39k | 17,902 | May 6, 2025 |
| May 2, 2025 | PBH Prestige Consumer Healthcare Inc. | FTax withholding Common Stock, par value $0.01 per share | -505 | $84.19 | $43k | 17,397 | May 6, 2025 |
| May 5, 2025 | PBH Prestige Consumer Healthcare Inc. | AGrant or award Common Stock, par value $0.01 per share | +2,464 | $0.00 | $0 | 19,861 | May 6, 2025 |
| May 5, 2025 | PBH Prestige Consumer Healthcare Inc. | FTax withholding Common Stock, par value $0.01 per share | -1,118 | $82.98 | $93k | 18,743 | May 6, 2025 |
| Nov 12, 2024 | PBH Prestige Consumer Healthcare Inc. | MOption exercise Common Stock, par value $0.01 per share | +5,565 | $44.33 | $247k | 27,428 | Nov 14, 2024 |
| Nov 12, 2024 | PBH Prestige Consumer Healthcare Inc. | SOpen-market sale Common Stock, par value $0.01 per share | -9,063 | $82.00 | $743k | 18,365 | Nov 14, 2024 |
| Nov 12, 2024 | PBH Prestige Consumer Healthcare Inc. | MOption exercise Employee Stock Options (rights to buy)derivative | -5,565 | $0.00 | $0 | 5,400 | Nov 14, 2024 |
Questions about Adel Mekhail
Answered from the filings on this page, as of the latest one.
Is Adel Mekhail buying or selling?
Not in the last 12 months. Adel Mekhail's latest open-market trade on SEC Form 4 was sold $743k of PBH on Nov 12, 2024.
How did Adel Mekhail's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Adel Mekhail has 0.
Where does Adel Mekhail file Form 4?
Adel Mekhail has filed Form 4 at PBH (Prestige Consumer Healthcare Inc.) as EVP, Marketing & Sales. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.